Roger's 1997 Short Picks Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Roger's 1997 Short Picks

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ricardo A. Biondi who wrote (8089)	12/10/1997 2:34:00 PM
From: Bill Wexler	Read Replies (5) of 9285

Here's one we should take a serious look at - ZONA This is another development stage drug company working on - you guessed it - an erectile dysfunction drug. Unfortunately, it looks like Zonagen's flagship product, Vasomax, has only one active ingredient: a 45-year old generic drug named phentolamine, and it seems that their phase II and III trials were a bust. Manuel Asensio recently wrote a report blasting the company: biz.yahoo.com It is currently trading at 29 - 30 a share. It hit an all-time high of 45 after being touted by Volpe-Brown and Westergaard (sheesh!), and the stock seems to be struggling. Check out the ZONA thread on SI and Motley Fool. looks like a lot of touting and true believers. I wouldn't recommend posting on either one because you will probably get skinned alive. This one looks like another winner. I'm short at 30.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next